Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibitors is associated with poor outcomes in metastatic...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2023-09-01
|
| Schriftenreihe: | Immuno-Oncology and Technology |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S259001882300014X |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|